Results 261 to 270 of about 360,434 (351)

Neuropsychiatric sequelae in sporadic viral encephalitis.

open access: yesInd Psychiatry J
Chaudhury S   +4 more
europepmc   +1 more source

Reduced Hospital Incidence of Autoimmune Encephalitis During the COVID-19 Pandemic. [PDF]

open access: yesNeurol Neuroimmunol Neuroinflamm
Wickel J   +33 more
europepmc   +1 more source

Layer‐Specific Astrocyte Morphological Responses in the CA3 Hippocampus Region During Piry Virus‐Induced Encephalitis

open access: yesHippocampus, Volume 36, Issue 2, March 2026.
ABSTRACT Astrocytes from distinct hippocampal layers exhibit region‐specific morphological traits, which may be influenced by their local microenvironment. During viral encephalitis, these cells undergo dynamic changes that can reflect layer‐specific vulnerability. In this study, we characterized whether astrocytes from different CA3 hippocampal layers
Diego de Almeida Miranda   +10 more
wiley   +1 more source

Molecular Detection and Genetic Diversity of Measles and Parainfluenza Viruses Circulating in Humans in Bangladesh: A Cross‐Sectional Study

open access: yesHealth Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aims Among Paramyxoviruses (PMVs), measles virus (MeV) and human parainfluenza virus (HPIV) are major contributors to respiratory tract infections worldwide. Despite recurrent outbreaks of MeV and the significant health impact of HPIV, data on their molecular epidemiology and genetic diversity in Bangladesh remain scarce.
Shusmita Dutta Choudhury   +10 more
wiley   +1 more source

Long‐Term Clinical and Psychological Efficacy and Safety of Ocrelizumab in People With Multiple Sclerosis: A Real‐World Longitudinal Study

open access: yesHealth Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background Multiple sclerosis (MS) is the most prevalent immune‐mediated neurodegenerative disease affecting the central nervous system. Ocrelizumab, a humanized anti‐CD20 monoclonal antibody, has demonstrated significant efficacy in reducing disease activity and improving clinical outcomes of people with MS (PwMS) in clinical trials. However,
Majid Jafari   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy